Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBY
426
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $30.5M | 0.06% |
2,056,000
+244,700
| +14% | +$3.44M |
|
|
AMED
427
DELISTED
Amedisys
AMED
| $30.5M | 0.06% |
630,901
+282,600
| +81% | +$10.9M |
|
|
TYPE
428
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $30.4M | 0.06% |
1,271,200
+57,299
| +5% | +$1.34M |
|
429
Mohawk Industries
MHK
$9.42B
| $30.4M | 0.06% |
+159,200
| New | +$27.7M |
|
430
Exponent
EXPO
$3.24B
| $30.4M | 0.06% |
1,190,600
-4,800
| -0.4% | -$116K |
|
|
CALD
431
DELISTED
Callidus Software, Inc.
CALD
| $30.3M | 0.06% |
1,816,800
-415,600
| -19% | -$6.16M |
|
432
Dolby
DLB
$5.84B
| $30.3M | 0.06% |
696,300
+299,400
| +75% | +$11.1M |
|
433
Barclays
BCS
$94.6B
| $30.2M | 0.06% |
+3,739,871
| New | +$34.9M |
|
|
SBNY
434
DELISTED
Signature Bank
SBNY
| $30.1M | 0.06% |
221,374
+91,674
| +71% | +$12.5M |
|
|
NFBK
435
DELISTED
Northfield Bancorp
NFBK
| $30.1M | 0.06% |
1,832,368
+82,100
| +5% | +$1.28M |
|
436
VF Corp
VFC
$5.79B
| $30.1M | 0.06% |
+493,830
| New | +$28.7M |
|
437
Agilent Technologies
A
$42.2B
| $30.1M | 0.06% |
755,200
+707,200
| +1,473% | +$26.9M |
|
438
Valley National Bancorp
VLY
$8.3B
| $30M | 0.06% |
3,144,800
+796,100
| +34% | +$7.23M |
|
|
FBR
439
DELISTED
Fibria Celulose Sa
FBR
| $29.9M | 0.06% |
3,527,428
+1,810,628
| +105% | +$18.3M |
|
440
Hanmi Financial
HAFC
$963M
| $29.9M | 0.06% |
1,356,357
+70,226
| +5% | +$1.5M |
|
441
White Mountains Insurance
WTM
$5.11B
| $29.8M | 0.06% |
37,100
-1,100
| -3% | -$823K |
|
|
RAI
442
DELISTED
Reynolds American Inc
RAI
| $29.7M | 0.06% |
591,235
-354,300
| -37% | -$17.4M |
|
443
Gibraltar Industries
ROCK
$1.45B
| $29.7M | 0.06% |
1,039,153
+88,300
| +9% | +$2.06M |
|
|
UN
444
DELISTED
Unilever NV New York Registry Shares
UN
| $29.6M | 0.06% |
661,492
+310,777
| +89% | +$13.4M |
|
|
VAL
445
DELISTED
Valspar
VAL
| $29.6M | 0.06% |
276,400
+198,225
| +254% | +$16.4M |
|
446
BP
BP
$110B
| $29.6M | 0.06% |
1,164,370
+807,702
| +226% | +$20.4M |
|
|
CAJ
447
DELISTED
Canon, Inc.
CAJ
| $29.5M | 0.06% |
988,400
+239,000
| +32% | +$6.87M |
|
448
Waterstone Financial
WSBF
$385M
| $29.5M | 0.06% |
2,153,374
+67,400
| +3% | +$926K |
|
|
SAFM
449
DELISTED
Sanderson Farms Inc
SAFM
| $29.4M | 0.06% |
326,400
+42,983
| +15% | +$3.61M |
|
|
KKD
450
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $29.4M | 0.06% |
1,887,164
+553,135
| +41% | +$8.03M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.